BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia B, Liu H, Kong Q, Li B. Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma. Mol Cell Biochem. 2012;366:223-229. [PMID: 22466758 DOI: 10.1007/s11010-012-1299-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zou Q, Zhou E, Xu F, Zhang D, Yi W, Yao J. A TP73‐AS1/miR‐200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration. J Cell Biochem 2018;119:2189-99. [DOI: 10.1002/jcb.26380] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
2 Chen B, Chen B, Zhu Z, Ye W, Zeng J, Liu G, Wang S, Gao J, Xu G, Huang Z. Prognostic value of ZEB-1 in solid tumors: a meta-analysis. BMC Cancer 2019;19:635. [PMID: 31248382 DOI: 10.1186/s12885-019-5830-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hashiguchi M, Ueno S, Sakoda M, Iino S, Hiwatashi K, Minami K, Ando K, Mataki Y, Maemura K, Shinchi H. Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC). BMC Cancer. 2013;13:572. [PMID: 24304617 DOI: 10.1186/1471-2407-13-572] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 5.6] [Reference Citation Analysis]
4 Wang YY, Vadhan A, Chen PH, Lee YL, Chao CY, Cheng KH, Chang YC, Hu SC, Yuan SF. CD44 Promotes Lung Cancer Cell Metastasis through ERK-ZEB1 Signaling. Cancers (Basel) 2021;13:4057. [PMID: 34439211 DOI: 10.3390/cancers13164057] [Reference Citation Analysis]
5 Li X, Huang R, Li RH, Trope CG, Nesland JM, Suo Z. Expression of zinc finger E-box-binding homeobox factor 1 in epithelial ovarian cancer: A clinicopathological analysis of 238 patients. Mol Clin Oncol 2016;4:18-22. [PMID: 26870350 DOI: 10.3892/mco.2015.662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 Li D, Cheng P, Wang J, Qiu X, Zhang X, Xu L, Liu Y, Qin S. IRF6 Is Directly Regulated by ZEB1 and ELF3, and Predicts a Favorable Prognosis in Gastric Cancer. Front Oncol 2019;9:220. [PMID: 31019894 DOI: 10.3389/fonc.2019.00220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
7 Zhang Y, Liu G, Wu S, Jiang F, Xie J, Wang Y. Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer. Onco Targets Ther 2016;9:1303-10. [PMID: 27099512 DOI: 10.2147/OTT.S96723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
8 Murai T, Yamada S, Fuchs BC, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Tanabe KK, Kodera Y. Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer. J Surg Oncol 2014;109:684-9. [PMID: 24453058 DOI: 10.1002/jso.23564] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
9 Wang W, Hu W, Wang Y, Yang J, Yue Z. MicroRNA-508 is downregulated in clear cell renal cell carcinoma and targets ZEB1 to suppress cell proliferation and invasion. Exp Ther Med 2019;17:3814-22. [PMID: 30988768 DOI: 10.3892/etm.2019.7332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yuan CX, Zhou ZW, Yang YX, He ZX, Zhang X, Wang D, Yang T, Pan SY, Chen XW, Zhou SF. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells. Drug Des Devel Ther 2015;9:1293-318. [PMID: 25767376 DOI: 10.2147/DDDT.S74964] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
11 Ramírez-Moya J, Baker AR, Slack FJ, Santisteban P. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity. Oncogene 2020;39:3738-53. [PMID: 32157211 DOI: 10.1038/s41388-020-1248-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
12 Llorens MC, Rossi FA, García IA, Cooke M, Abba MC, Lopez-Haber C, Barrio-Real L, Vaglienti MV, Rossi M, Bocco JL, Kazanietz MG, Soria G. PKCα Modulates Epithelial-to-Mesenchymal Transition and Invasiveness of Breast Cancer Cells Through ZEB1. Front Oncol 2019;9:1323. [PMID: 31828042 DOI: 10.3389/fonc.2019.01323] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
13 Shi Q, He Q, Wei J. MicroRNA-342 Prohibits Proliferation and Invasion of Melanoma Cells by Directly Targeting Zinc-Finger E-Box-Binding Homeobox 1. Oncol Res 2018;26:1447-55. [PMID: 29495972 DOI: 10.3727/096504018X15193823766141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 Terashita K, Chuma M, Hatanaka Y, Hatanaka K, Mitsuhashi T, Yokoo H, Ohmura T, Ishizu H, Muraoka S, Nagasaka A, Tsuji T, Yamamoto Y, Kurauchi N, Shimoyama N, Toyoda H, Kumada T, Kaneoka Y, Maeda A, Ogawa K, Natsuizaka M, Kamachi H, Kakisaka T, Kamiyama T, Taketomi A, Matsuno Y, Sakamoto N. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma. J Clin Pathol 2016;69:593-9. [DOI: 10.1136/jclinpath-2015-203115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
15 Chen H, Lu W, Huang C, Ding K, Xia D, Wu Y, Cai M. Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis. Oncotarget 2017;8:31435-48. [PMID: 28416756 DOI: 10.18632/oncotarget.15634] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
16 Madany M, Thomas T, Edwards LA. The Curious Case of ZEB1. Discoveries (Craiova) 2018;6:e86. [PMID: 32309604 DOI: 10.15190/d.2018.7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Molaei F, Forghanifard MM, Fahim Y, Abbaszadegan MR. Molecular Signaling in Tumorigenesis of Gastric Cancer. Iran Biomed J. 2018;22:217-230. [PMID: 29706061 DOI: 10.22034/ibj.22.4.217] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
18 Wu L, Zhang Y, Huang Z, Gu H, Zhou K, Yin X, Xu J. MiR-409-3p Inhibits Cell Proliferation and Invasion of Osteosarcoma by Targeting Zinc-Finger E-Box-Binding Homeobox-1. Front Pharmacol 2019;10:137. [PMID: 30846940 DOI: 10.3389/fphar.2019.00137] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
19 Dutta A, Maji N, Sengupta P, Banerjee N, Kar S, Mukherjee G, Chatterjee S, Basu M. Promoter G-quadruplex favours epigenetic reprogramming-induced atypical expression of ZEB1 in cancer cells. Biochim Biophys Acta Gen Subj 2021;1865:129899. [PMID: 33930476 DOI: 10.1016/j.bbagen.2021.129899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Karihtala P, Auvinen P, Kauppila S, Haapasaari K, Jukkola-vuorinen A, Soini Y. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype. Breast Cancer Res Treat 2013;138:81-90. [DOI: 10.1007/s10549-013-2442-0] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 8.8] [Reference Citation Analysis]
21 Yang R, Liu Y, Wang Y, Wang X, Ci H, Song C, Wu S. Low PRRX1 expression and high ZEB1 expression are significantly correlated with epithelial-mesenchymal transition and tumor angiogenesis in non-small cell lung cancer. Medicine (Baltimore) 2021;100:e24472. [PMID: 33530259 DOI: 10.1097/MD.0000000000024472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yabusaki N, Yamada S, Murai T, Kanda M, Kobayashi D, Tanaka C, Fujii T, Nakayama G, Sugimoto H, Koike M. Clinical significance of zinc-finger E-box binding homeobox 1 mRNA levels in peritoneal washing for gastric cancer. Mol Clin Oncol. 2015;3:435-441. [PMID: 25798282 DOI: 10.3892/mco.2014.462] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
23 Lin S, Song S, Sun R, Zhang M, Du Y, Zhang D, Xu W, Wang H. Oncogenic circular RNA Hsa‐circ‐000684 interacts with microRNA‐186 to upregulate ZEB1 in gastric cancer. FASEB j 2020;34:8187-203. [DOI: 10.1096/fj.201903246r] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
24 Gao H, Sun X, Wang H, Zheng Y. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer. Cell Cycle 2020;19:1186-99. [PMID: 32306838 DOI: 10.1080/15384101.2020.1749466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
25 Liu YY, Zhang LY, Du WZ. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p. Biosci Rep. 2019;39. [PMID: 31793989 DOI: 10.1042/bsr20193045] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 21.0] [Reference Citation Analysis]
26 Evans JC, Malhotra M, Sweeney K, Darcy R, Nelson CC, Hollier BG, O'Driscoll CM. Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours. Int J Pharm 2017;532:511-8. [PMID: 28916296 DOI: 10.1016/j.ijpharm.2017.09.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
27 Ang L, Zheng L, Wang J, Huang J, Hu HG, Zou Q, Zhao Y, Liu QM, Zhao M, Wu ZS. Expression of and correlation between BCL6 and ZEB family members in patients with breast cancer. Exp Ther Med 2017;14:3985-92. [PMID: 29104620 DOI: 10.3892/etm.2017.5101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
28 Widmer DS, Hoek KS, Cheng PF, Eichhoff OM, Biedermann T, Raaijmakers MIG, Hemmi S, Dummer R, Levesque MP. Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching. J Invest Dermatol 2013;133:2436-43. [PMID: 23474946 DOI: 10.1038/jid.2013.115] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 10.9] [Reference Citation Analysis]
29 Sztukowska MN, Ojo A, Ahmed S, Carenbauer AL, Wang Q, Shumway B, Jenkinson HF, Wang H, Darling DS, Lamont RJ. Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells. Cell Microbiol 2016;18:844-58. [PMID: 26639759 DOI: 10.1111/cmi.12554] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
30 Zhu X, Li W, Zhang R, Liu Y. MicroRNA-342 inhibits cell proliferation and invasion in nasopharyngeal carcinoma by directly targeting ZEB1. Oncol Lett 2018;16:1298-304. [PMID: 30061949 DOI: 10.3892/ol.2018.8788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
31 Zhang P, Sun Y, Ma L. ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle 2015;14:481-7. [PMID: 25607528 DOI: 10.1080/15384101.2015.1006048] [Cited by in Crossref: 251] [Cited by in F6Publishing: 261] [Article Influence: 35.9] [Reference Citation Analysis]
32 Zhuang MK, Chen FL. Biomarkers of epithelial-mesenchymal transition in gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(30): 3204-3210 [DOI: 10.11569/wcjd.v21.i30.3204] [Reference Citation Analysis]